Life Without a Stomach: Maori Families, CDH1 Mutation, and Preventive Gastric Cancer Surgery

Short summary

In this NPR Short Wave episode, reporters trace Maori family histories that reveal a hereditary CDH1 mutation associated with diffuse gastric cancer, explaining how tests, risk assessment, and preventive gastrectomy reshape lives and communities. The story blends genetic sleuthing, medical decision making, and personal transformation as families confront challenging choices and seek stronger scientific answers.

• Maori families show a pattern of stomach cancer linked to a single gene mutation
• Testing can reveal a 70% lifetime risk and prompt drastic preventive surgery
• Gastrectomy reshapes eating, social life, and long-term health management
• Researchers and clinicians discuss evolving options and the ethics of prevention

Overview

The podcast follows a medical mystery that begins in Maori families and centers on a gene called CDH1. Diffuse gastric cancer, a form that hides in the lining of the stomach, can be difficult to detect until it is too late. The episode explains how researchers traced the cancer pattern to a hereditary mutation in the CDH1 gene, and how a family-based approach helped scientists map how the mutation runs through generations. The story underscores the power and limits of genetic testing: a positive result may carry a 70 percent chance of developing this aggressive cancer, leaving individuals facing high-stakes choices about their future health.

The host and reporter accompany listeners through the science of the CDH1 gene, which encodes a protein that normally helps orient and align stomach cells. When this protein is deficient, cells may become rogue and cancerous. The episode conveys how a single genetic clue can illuminate a broader medical narrative, while also highlighting the human dimensions of genetic risk, including family dynamics, stigma, and the burden of surveillance versus intervention.

Quote

"Now, this gene encodes a protein that normally orients and aligns cells in the stomach" - Sarah Zhang, Atlantic staff writer

CDH1, diffuse gastric cancer, and Maori families

The episode details how Maori families, already dealing with stomach cancer in multiple relatives, discovered a unifying genetic thread. In the 1990s, researchers identified a mutation in the CDH1 gene that disrupts a protein essential for maintaining the organization of stomach tissue. The line of relatives who developed diffuse gastric cancer helped push scientists to search for common genetic roots, ultimately revealing a pattern of inherited risk. Any parent with a CDH1 mutation has a 50 percent chance of passing it on to children, which helps explain why this cancer runs through generations in some families.

The story emphasizes the complexity of translating a genetic finding into clinical action. While a positive test confers a high risk, it also brings substantial tradeoffs: surveillance options carry ongoing anxiety and invasive procedures, whereas a prophylactic surgery—removing the stomach—offers a potential life-saving benefit but imposes lifelong changes in digestion, nutrition, and social life. The podcast presents this as a nuanced medical dilemma rather than a straightforward choice.

Quote

"This gene encodes a protein that normally orients and aligns cells in the stomach" - Sarah Zhang, Atlantic staff writer

May Belle McLeod and the science sleuthing

May Belle McLeod, a Maori woman and nurse, emerges as a central figure in the genetic sleuthing that connected family history to a concrete genetic cause. The episode recounts her decision to engage with scientists at a genetics conference, transforming what once felt like a curse into a testable, researchable truth. The narrative portrays a leadership arc in which a community member shifts from avoidance to active participation in research, enabling the broader Maori family to contribute samples and reconstruct their family tree across generations.

The collaborative process described—families collecting samples themselves, building a family tree, and sharing data with researchers—illustrates a paradigm in which patients and families actively shape genetic research rather than waiting for external investigators to knock on doors. This model helps explain how a small community made a meaningful contribution to cancer genetics and to understanding how a mutation travels through a lineage.

Gastrectomy, life without a stomach, and social implications

Karen Paringitai, a Maori studies professor, represents the personal face of the medical calculus. She learns she carries the CDH1 mutation, and in 2010 she chooses to undergo a gastrectomy—removing the stomach to prevent cancer. The description of the procedure emphasizes its invasiveness: a major surgery that reconfigures the digestive tract, necessitating years of adaptation. Immediately after surgery, patients often rely on soft foods, must chew meticulously, and adjust to new dining patterns with friends and family, as social life and physical stamina shift during recovery. The narrative emphasizes that nutrition and blood sugar management change, and even routine activities like drinking water can present unexpected challenges, underscoring the individualized nature of post-surgical outcomes.

As patients adapt, the body reorganizes to compensate. The upper intestine forms a pseudo stomach, and with time some patients can tolerate larger portions, though the need for regular injections such as vitamin B12 persists because the stomach is central to certain nutrient processing. The episode also documents variability in long-term quality of life: some regain energy and stamina, while others continue to face fatigue, nausea, or vomiting in different degrees. It also highlights how these life changes ripple through work, social life, and family relationships.

Quote

"We’ll think these surgeries are draconian. We can't believe, I can't believe we were doing such draconian surgeries on people taking their whole stomachs out" - Perry Guilford, geneticist

Medical progress, risks, and the ethical landscape

The podcast closes with reflection on where medicine stands today. Genetic testing makes risk assessment possible in unprecedented ways, yet preventive surgeries remain among the most invasive interventions in modern medicine. The geneticist voices a cautious forward-looking view: in the future, doctors may find less draconian means to prevent cancer, and they may refine how to weigh physical and psychological side effects against life expectancy benefits. The host frames Karen’s case as emblematic of a broader shift toward personalized medicine, in which a patient’s family history, genetic makeup, and personal values increasingly guide decisions about risk reduction. The episode ends on a note of resilience and collaboration, with the Maori community contributing to cancer research and a professor using her experiences to connect cultural understanding with scientific inquiry.

Quote

"She feels like it saved her life" - Emily Kwong